Rebecca Taub
2021
Compensation breakdown
| Non-Equity Incentive Plan | $344,246 |
|---|---|
| Option Awards | $3,755,400 |
| Salary | $510,500 |
| Total | $4,610,146 |
Taub received $3.8M in option awards, accounting for 81% of the total pay in 2021.
Taub also received $344.2K in non-equity incentive plan and $510.5K in salary.
Rankings
In 2021, Rebecca Taub's compensation ranked 2,866th out of 12,415 executives tracked by ExecPay. In other words, Taub earned more than 76.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,866 out of 12,415 | 77th |
Division Manufacturing | 1,140 out of 5,505 | 79th |
Major group Chemicals And Allied Products | 451 out of 2,375 | 81st |
Industry group Drugs | 395 out of 2,096 | 81st |
Industry Pharmaceutical Preparations | 264 out of 1,546 | 83rd |
Pay ratio
| Rebecca Taub's Pay | $4,610,146 |
|---|---|
| Median Employee's Pay | $459,419 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of Rebecca Taub was $4,610,146.
The annual total compensation of the median employee at Synta Pharmaceuticals was $459,419.
The ratio of Rebecca Taub's pay to the pay of median employee was therefore 10 to one.
Taub's colleagues
We found five more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2021.
2021
Alex Howarth
Synta Pharmaceuticals
Chief Financial Officer
2021
Paul Friedman
Synta Pharmaceuticals
Chief Executive Officer
2021
Marc Schneebaum
Synta Pharmaceuticals
Chief Financial Officer
2021
Brian Lynch
Synta Pharmaceuticals
General Counsel
2021
Remy Sukhija
Synta Pharmaceuticals